Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason A Roberts

Showing results (511-520 of 609) with videos related to

Pageof 61
Sort By:
Antimicrobial Agents and Chemotherapy|July 15, 2020
Pharmacodynamic Evaluation of Plasma and Epithelial Lining Fluid Exposures of Amikacin against Pseudomonas aeruginosa in a Dynamic <i>In Vitro</i> Hollow-Fiber Infection ModelAaron J Heffernan, Fekade B Sime, Derek S Sarovich, et al.
Critical Care and Resuscitation : Journal of the Australasian Academy of Critical Care Medicine|June 16, 2012
Development of simulated and ovine models of extracorporeal life support to improve understanding of circuit-host interactionsKiran Shekar, Yoke L Fung, Sara Diab, et al.
Critical Care (London, England)|June 3, 2014
Does contemporary vancomycin dosing achieve therapeutic targets in a heterogeneous clinical cohort of critically ill patients? Data from the multinational DALI studyStijn Blot, Despoina Koulenti, Murat Akova, et al.
Critical Care (London, England)|April 19, 2015
Pharmacokinetic variability and exposures of fluconazole, anidulafungin, and caspofungin in intensive care unit patients: Data from multinational Defining Antibiotic Levels in Intensive care unit (DALI) patients StudyMahipal G Sinnollareddy, Jason A Roberts, Jeffrey Lipman, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 17, 2014
DALI: defining antibiotic levels in intensive care unit patients: are current β-lactam antibiotic doses sufficient for critically ill patients?Jason A Roberts, Sanjoy K Paul, Murat Akova, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|December 29, 2024
Population pharmacokinetics and dosing simulations of temocillin in liver-transplanted paediatric patients: a prospective, open-label, non-randomized studyPerrin Ngougni Pokem, Xavier Stéphenne, Xin Liu, et al.
Clinical Pharmacokinetics|August 30, 2022
Nafamostat Mesylate for Treatment of COVID-19 in Hospitalised Patients: A Structured, Narrative ReviewMaría Patricia Hernández-Mitre, Steven Y C Tong, Justin T Denholm, et al.
International Journal of Antimicrobial Agents|April 23, 2026
Population pharmacokinetics of total and free ceftriaxone in critically ill and non-critically ill hospitalised adult patientsEko Setiawan, Alvaro Gonzalez, Saskia A Wölky, et al.
Diagnostic Microbiology and Infectious Disease|June 6, 2025
A global survey of diagnostic practices in prosthetic joint infectionsShradha Subedi, Patrick Na Harris, Paul Chapman, et al.
Intensive Care Medicine|January 13, 2016
Beta-Lactam Infusion in Severe Sepsis (BLISS): a prospective, two-centre, open-labelled randomised controlled trial of continuous versus intermittent beta-lactam infusion in critically ill patients with severe sepsisMohd H Abdul-Aziz, Helmi Sulaiman, Mohd-Basri Mat-Nor, et al.
Pageof 61

Showing results (511-520 of 609) with videos related to

Sort By:
Pageof 61
Antimicrobial Agents and Chemotherapy|July 15, 2020
Pharmacodynamic Evaluation of Plasma and Epithelial Lining Fluid Exposures of Amikacin against Pseudomonas aeruginosa in a Dynamic <i>In Vitro</i> Hollow-Fiber Infection ModelAaron J Heffernan, Fekade B Sime, Derek S Sarovich, et al.
Critical Care and Resuscitation : Journal of the Australasian Academy of Critical Care Medicine|June 16, 2012
Development of simulated and ovine models of extracorporeal life support to improve understanding of circuit-host interactionsKiran Shekar, Yoke L Fung, Sara Diab, et al.
Critical Care (London, England)|June 3, 2014
Does contemporary vancomycin dosing achieve therapeutic targets in a heterogeneous clinical cohort of critically ill patients? Data from the multinational DALI studyStijn Blot, Despoina Koulenti, Murat Akova, et al.
Critical Care (London, England)|April 19, 2015
Pharmacokinetic variability and exposures of fluconazole, anidulafungin, and caspofungin in intensive care unit patients: Data from multinational Defining Antibiotic Levels in Intensive care unit (DALI) patients StudyMahipal G Sinnollareddy, Jason A Roberts, Jeffrey Lipman, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 17, 2014
DALI: defining antibiotic levels in intensive care unit patients: are current β-lactam antibiotic doses sufficient for critically ill patients?Jason A Roberts, Sanjoy K Paul, Murat Akova, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|December 29, 2024
Population pharmacokinetics and dosing simulations of temocillin in liver-transplanted paediatric patients: a prospective, open-label, non-randomized studyPerrin Ngougni Pokem, Xavier Stéphenne, Xin Liu, et al.
Clinical Pharmacokinetics|August 30, 2022
Nafamostat Mesylate for Treatment of COVID-19 in Hospitalised Patients: A Structured, Narrative ReviewMaría Patricia Hernández-Mitre, Steven Y C Tong, Justin T Denholm, et al.
International Journal of Antimicrobial Agents|April 23, 2026
Population pharmacokinetics of total and free ceftriaxone in critically ill and non-critically ill hospitalised adult patientsEko Setiawan, Alvaro Gonzalez, Saskia A Wölky, et al.
Diagnostic Microbiology and Infectious Disease|June 6, 2025
A global survey of diagnostic practices in prosthetic joint infectionsShradha Subedi, Patrick Na Harris, Paul Chapman, et al.
Intensive Care Medicine|January 13, 2016
Beta-Lactam Infusion in Severe Sepsis (BLISS): a prospective, two-centre, open-labelled randomised controlled trial of continuous versus intermittent beta-lactam infusion in critically ill patients with severe sepsisMohd H Abdul-Aziz, Helmi Sulaiman, Mohd-Basri Mat-Nor, et al.
Pageof 61